background image

Obstetrics                                                                                                                 Dr. esra 

 

 

Venous Thromboembolism 

VTE 

 

 

 

VTE is most common cause of maternal mortality in UK. 
Pregnancy is hypercoagulable state because of: 
1. alteration in thrombotic & fibrinolytic system. 
2. There is increase in clotting factors VIII, IX, X & fibrinogen level. 
3. There is reduction in protein S & antithrombin III (AT III)concentration. 
 
 
The net result is : 
1. to reduce the likelihood of haemorrhage  following delivery. 
2.  at  same  time  predispose  women  to  thromboembolism  that  exacerbated  by  venous 
stasis  in  lower  limb  due  to  weight  of  gravid  uterus  placing  pressure  on  IVC  in  late 
pregnancy & puerperium. 
More common in Left side due to compression of left iliac vein by left iliac artery 

 
Thrombophilia: 

Acquired or hereditary. 
Deficiency of anticoagulant protein C, protein S & AT III. 
Associated with several pregnancy complication: recurrent fetal loss, placental abruption 
, IUGR & thromboembolism. 

 
Antiphosphlipid syndrome: 

 

APS: is acquired form of thrombophilia. 
Diagnosis of APS require at least one of following:  
3 or more unexplained consecutive spontaneous abortion before 10th of pregnancy with 
maternal anatomical or hormonal abnormalities & paternal and maternal chromosomal 
abnormalities excluded. 
1 or more unexplained death of morphological normal fetus at or beyond 10th week of 
gestation. 
1 or more premature birth of morphological normal neonate at or before 34th week 
because of PE orE or placental insufficiency . 
 


background image

Obstetrics                                                                                                                 Dr. esra 

 

                                                                                                                                                                                                                                               
In addition persistent abnormality of one of following tests when measured at least twice 
more than 6 wk apart : 
 -  Lupus anticoagulant  
-  Anticardiolipin antibody 
 

Risk factors for VTE 

 

Pre-existing:                                            
1-Maternal age ˃ 35 
2-Thrombophilia 
3-Obesity ˃ 80 kg 
4-Previous th.embolism 
5-Severe varicose veins 
6-Smoking  
7-Malignancy 
 
Specific to pregnancy: 
1-Multiple gestation 
2-Pre-eclampsia 
3-Grand multiparity 
4-CS , especially emergency 
5-Damage to pelvic veins 
6-Sepsis 
7-Prolonged bed rest 
 

DX of acute VTE: 

DVT:   

1-  Symptoms : calf pain with redness & swelling especially unilateral, calf is tender to 

touch   

2-   Doppler ultrasound 
3-   venography : is invasive require injection of contrast medium & use of x-ray   

Pulmonary embolism: 

1. symptoms : mild breathlessness, inspiratory chest pain, tachycardia , mild pyrexia 37.5  
    massive PE there will be acute cardio-respiratory collapse. 
 
2. ECG, CXR, & arterial blood gas analysis to exclude other condition. 
 
3. Lower limb ultrasound for evidence of DVT . 


background image

Obstetrics                                                                                                                 Dr. esra 

 

 
 
4. If all tests are normal with high clinical suspicion, a ventilation-perfusion scan or 
pulmonary angiography should be performed. 
5. D- dimer: in pregnancy low level exclude DVT or PE, while increase level of D-dimer 
suggest thrombosis , D –dimer level may be elevated in normal pregnancy due to 
physiological changes of pregnancy. 
 

Treatment of VTE: 

1-Warfarin cross the placenta & cause warfarin embryopathy (limb & facial defect) in 1st trimester 

& fetal intracerebral haemrrhage in 2nd & 3rd trimester. 

2-heparin (LMWH or unfractionated) are treatment of choice , not cross placenta . Prolonged use 

may cause bleeding , osteoparosis, thrpmbocytopenia & allergy. 

The potential advantages of LMWH over UFH is less risk of bleeding . 
 
UFH cause dose dependent loss of bone , if administered for more than one 
month . LMWH carry a much lower risk of osteoparosis. 
Heparin induced thrombocytopenia HIT is another complication of UFH , this 
risk is lower with LMWH. 
Allergy to UFH or LMWH take the form of itchy, erythematous lesion at injection 
site. Changing preparation or shifting to other type may help. 

 
The  woman  taking  LMWH  therapy  should  be  advised  that  once  she  is  established  in 
labour or thinks that she is in labor, she should not inject any further heparin.  
Where delivery is planned, LMWH maintenance therapy should be discontinued 24 hours 
before planned delivery. 
 Regional  anesthetic  or  analgesic  techniques  should  not  be  undertaken  until  at  least  24 
hours after the last dose of therapeutic LMWH . 
Heparin  anticoagulation  (LMWH  or  UFH)  may  be  restarted  3–6  h  after  vaginal  delivery 
and 6–8 h after cesarean. Warfarin anticoagulation may be started postpartum day 1. 
Following    delivery  women  can  convert  to  warfarin  with  checking  of  INR  or  remain  on 
LMWH. Both are safe in breast feeding mother . 
If  spontaneous  labor  occurs  while  receiving  LMWH,  anticoagulant  effect  depends  on 
timing of last dose, Avoid epidural, Protamine can be considered. 

 
 
 


background image

Obstetrics                                                                                                                 Dr. esra 

 

 
Antenatal thromboprophylaxis: 

high risk-----antenatal LMWH: 

1-Single previous VTE +  
2-Thrombophilia  
3-Family history  
4-Estrogen related previous recurrent VTE. 

intermediate risk -- antenatal LMWH 

1-Single previous VTE with no family HX or thrombophilia  
2-Thrombophilia & no HX of VTE  
3-Medical co-morbidity: SLE, cancer, inflammatory condition, nephrotic syndrome, sickle 
cell disease , iv drug user 
4-Surgical procedure: appendicectomy. 
 
Age ˃ 35 yr 
Obesity BMI ˃ 30 kg\m2 
Parity 3 or more 
Smoker 
Gross varicose vein 
Current infection 
Immobility eg long distance travel, paraplegia 
Preeclampsia  
Dehydration , hyperemesis gravidarum. 
Multiple pregnancy 
→ 3 or more risk factors----high risk ----antenatal prophylaxis 
→˂ 3 risk factors----intermediate----mobilization & avoidance of dehydration. 
 

Postnatal thromboprophylaxis: 

 
1-Any previous VTE. 

 

2-Any one requiring antenatal LMWH. 
→High risk : at least 6 wk postnatal prophylactic LMWH 
 
 
CS in labour 
Asymptomatic thrombophilia 
BMI ˃40 kg\ m2 
Prolonged hospital admission 


background image

Obstetrics                                                                                                                 Dr. esra 

 

Medical co-morbidity: heart or lung disease, SLE, cancer, inflammatory condition, 
nephrotic syndrome, sickle cell disease , iv drug user. 
→intermediate risk : 7 days postnatal LMWH, if more than 3 risk factors, consider 
extended px with LMWH.Thyroid Disease In Pregnancy 
 
Age ˃ 35 yr 
Pariry ≥ 3 
Obesity BMI ˃ 30 kg\m2 
Smoker 
Elective CS 
Elective surgical procedure in puerperium 
Gross varicose vein 
Current systemic infection 
Immobility 
Preeclampsia 
Mid cavity rotational forceps delivery 
Prolonged labour ˃24 hr 
PPH  
→2 or more risk factors--- 7 days px LMWH 
  ˂ 2 risk factors-----low risk : mobilization & avoidance of dehydration 

 

 

Normal physiology in pregnancy 

   in pregnancy threre is decrease in level of iodine due to increase in renal 

excretion of (increase in GFR ), plasma vol. expansion . 

   TSH fall ,serum level of total T3 & total T4 increased, fT4 rise in 1

st

 

trimester followed by fall in advancing gestation (due to increased TBG )& 
is the only accurate measure for estimation of TF in pregnancy. 

 

Fetal thyroid function 

  By 11- 12 wk the fetal thyroid is able to produce T4 & by 12-14 wk , it is 

able to concentrate  iodine 

 

Placental transfer of thyroid hormones 

  Iodine cross placenta  
  T4 minimally cross placenta & appear to be important in fetal neuronal 

development in 1

st

 trimester before fetal thyroid function begins. 

  ATD such as propylthiouracil & methimazole cross placenta & can cause 

fetal hypothyroidism 


background image

Obstetrics                                                                                                                 Dr. esra 

 

 

Maternal hyperthyroidism 

  Increase risk of prematurity, IUGR, PE, stillbirth, neonatal M & M. 
  Most common cause is Graves disease , which is an Auto- immune disease 

characterize by TSH receptor stimulating antibodies . Patient with graves 
disease tend to have remission during pregnancy & relapse postpartum.  

  Clinical features: clinical DX is difficult during pregnancy , because many of 

S & S of hyperthyroidism  are present in normal pregnancy. PR more than 
100 b\m which fail to slow with valsalva manoeuvre, eye changes, wt loss  
& heat intolerance are helpful in making DX. 

  Investigation : increase in serum free T4 & Suppressed TSH level  
  Treatment : 
1. radio-active iodine is contraindicated in pregnancy. 
2. Anti thyroid drugs  are main stay of treatment: thiomides block synthesis 

of thyroid hormones, such as propylthiouracil & methimazole , in the 
lowest effective dose should be used to keep fT3 & fT4 at upper normal 
range. B-blocker can be used also. During breast feeding PTU can be used 
because execretion in breast milk is minimal. 

3. Surgical treatment : if medical Rx is failed ,or if there is suspicion of 

malignancy can be done in 2

nd

 trismester 

 

Neonatal thyrotoxicosis 

  1% of pregnant women with graves disease give birth to babies with  

thyrotoxicosis due to transplacental transfer of thyroid stimulating 
antibodies. 

  Transient lasts less then 2-3 months . 
  Can be suspected if baseline FHR more then 160 b\m & ULS can identify 

fetal goitre. 

  Is associated with high PNM&M , after delivery TF should be measured in 

cord Bd & should be treated pre & postnatally. 

 

Hypothyroidism 

  Pregnant women with appropriate thyroid replacement can expect normal 

outcome. 

  Untreated cases are associated with spontaneous miscarriage, PE, 

abruption ,LBW, low IQ in offspring. 


background image

Obstetrics                                                                                                                 Dr. esra 

 

  Dx : elevated TSH. 
  Rx : levothyroxine , full thyroid replacement & biochemical euothyroidism 

is the aim. TFT should be performed each trimester with appropriate 
adjustment of the dose 

 

Neonatal hypothyroidism 

  Thyroid hr deficiency in fetal & early neonatal period lead to generalized 

developmental retardation. 

  Etiology: thyroid dysgenesis , inborn error of thyroid function, drug 

induced hypothyroidism. 
 

BY:TWANA NAWZAD 




رفعت المحاضرة من قبل: Mohammed Musa
المشاهدات: لقد قام 11 عضواً و 92 زائراً بقراءة هذه المحاضرة








تسجيل دخول

أو
عبر الحساب الاعتيادي
الرجاء كتابة البريد الالكتروني بشكل صحيح
الرجاء كتابة كلمة المرور
لست عضواً في موقع محاضراتي؟
اضغط هنا للتسجيل